- Tytuł:
- Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Evidence Assessment Group Perspective
- Autorzy:
- Źródło:
- PharmacoEconomics. 42(2):133-136
Czasopismo naukowe